Screener
Pulse Biosciences, Inc. PLSE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s total equity?
- Pulse Biosciences, Inc. (PLSE) reported total equity of $99.5M in Q2 2026.
- How has Pulse Biosciences, Inc.'s total equity changed year-over-year?
- Pulse Biosciences, Inc.'s total equity decreased by 4.8% year-over-year, from $104.49M to $99.5M.
- What is the long-term trend for Pulse Biosciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total equity has grown at a 28.6% compound annual growth rate (CAGR), from $22.89M to $80.66M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Pulse Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude